Self-confidence Study in Patients With Argus II Artificial Retina

See also
Status	Clinical Trial	Phase
Completed	`NCT05179460` - A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
Recruiting	`NCT04360291` - Impact of Visual Field Restriction on Visual Exploration
Recruiting	`NCT05643157` - Cellular Scale Measures of Short-Term Retinal Atrophy Progression
Recruiting	`NCT04419285` - Mobility Protocol Adapted for Advanced Visually Impaired Subjects	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT05179460 - A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy

Recruiting

NCT04360291 - Impact of Visual Field Restriction on Visual Exploration

Recruiting

NCT05643157 - Cellular Scale Measures of Short-Term Retinal Atrophy Progression

Recruiting

NCT04419285 - Mobility Protocol Adapted for Advanced Visually Impaired Subjects

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03510234
Study type	Observational
Source	University Hospital, Strasbourg, France
Contact	David GAUCHER, MD, PhD
Phone	33 3 69 55 11 15
Email	david.gaucher@chru-strasbourg.fr
Status	Recruiting
Phase
Start date	February 23, 2018
Completion date	February 2019

Self-confidence Study in Patients With Argus II Artificial Retina

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms